Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · December 01, 2022

Association Between the Pancreatic Polypeptide Response and New-Onset Pancreatogenic Diabetes vs Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Clinical Endocrinology and Metabolism
A reduced pancreatic polypeptide response is associated with new onset pancreatogenic diabetes versus type 2 diabetes
J. Clin. Endocrinol. Metab. 2022 Nov 21;[EPub Ahead of Print], PA Hart, YC Kudva, D Yadav, DK Andersen, Y Li, FGS Toledo, F Wang, MD Bellin, D Bradley, RE Brand, K Cusi, W Fisher, K Mather, WG Park, Z Saeed, RV Considine, SC Graham, JA Rinaudo, J Serrano, MO Goodarzi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading